Abstract: The present invention relates to novel cGAS inhibitor compounds, having a formula of (IIa) to pharmaceutical compositions comprising the compounds, and to methods of using the compounds and compositions to treat certain pathological conditions such as immune-mediated diseases.
| # | Name | Date |
|---|---|---|
| 1 | 202517068767-STATEMENT OF UNDERTAKING (FORM 3) [18-07-2025(online)].pdf | 2025-07-18 |
| 2 | 202517068767-REQUEST FOR EXAMINATION (FORM-18) [18-07-2025(online)].pdf | 2025-07-18 |
| 3 | 202517068767-PRIORITY DOCUMENTS [18-07-2025(online)].pdf | 2025-07-18 |
| 4 | 202517068767-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [18-07-2025(online)].pdf | 2025-07-18 |
| 5 | 202517068767-FORM-26 [18-07-2025(online)].pdf | 2025-07-18 |
| 6 | 202517068767-FORM 18 [18-07-2025(online)].pdf | 2025-07-18 |
| 7 | 202517068767-FORM 1 [18-07-2025(online)].pdf | 2025-07-18 |
| 8 | 202517068767-DECLARATION OF INVENTORSHIP (FORM 5) [18-07-2025(online)].pdf | 2025-07-18 |
| 9 | 202517068767-COMPLETE SPECIFICATION [18-07-2025(online)].pdf | 2025-07-18 |
| 10 | 202517068767-FORM 3 [06-11-2025(online)].pdf | 2025-11-06 |